News

A 53-year-old male patient, previously diagnosed with genetic amyloidosis at Hanoi French Hospital in 2024, has successfully undergone a combined heart and liver…

Start dateThu, 03/19/2026 - 12:00End dateThu, 03/19/2026 - 12:00Venue - Full AddressKeble CollegeParks RoadOxfordOX1 3PGOrganiserBritish Society of Cardiovascular…

AbstractAmyloidosis is a systemic disease characterized by the extracellular deposition of the misfolded proteins resulting in organ dysfunction, frequently the…

Outpatient worsening heart failure (HF) may serve as an important clinical marker of disease progression and mortality in patients with transthyretin amyloidosis…

Eplontersen constitutes a promising improvement in the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR), according to a…

Amyloidosis is a group of protein-folding disorders characterized by the infiltration of multiple organs with amyloid deposits, primarily affecting the heart and…

AbstractPurpose of ReviewCardiac amyloidosis (CA) results from myocardial infiltration by misfolded amyloidogenic proteins and represents a heterogeneous group of…

Join us March 13-15, 2026, for the virtual Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management.Led by Program Chair, Saurabh Malhotra, MD…

Cardiac amyloidosis nuclear image. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.The American Society of Nuclear…

Transthyretin amyloidosis (ATTR) is a systemic disease characterized by the deposition of misfolded transthyretin (TTR) fibrils. It most commonly presents as…